64
Participants
Start Date
January 4, 2021
Primary Completion Date
September 30, 2023
Study Completion Date
September 30, 2023
Camrelizumab , apatinib and chemotherapy
"Camrelizumab 200 mg, IV infusion on Days 1 each 14-day cycle~Apatinib 250mg oral administration once a day, for two months~mFOLFOX6 oxaliplatin 85 mg/m\^2 IV infusion on Day 1 of each14-day cycle. Fluorouracil: 400 mg/m2 as a bolus injection given after a two-hour leucovorin infusion at a dose of 400 mg/m2. The loading dose is then followed by a 46-hour 5-fluorouracil infusion of 2,400 mg/m2 via a pump programmed to provide a constant drug infusion rate."
First affiliated hospital, Zhejiang University, Hangzhou
Zhejiang University
OTHER